DEVELOPMENT AND IN VITRO EVALUATION OF SOLID DISPERSIONS OF CANDESARTAN CILEXETIL

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 2

Abstract

Objective The main objective of the present study is systematic development of solid dispersions of Candesartan cilexetil by solvent evaporation method to enhance the solubility and bioavailability. Methods In the present study, eighteen formulations of solid dispersions were prepared with 1:1 and 1:3 ratios of drug: carrier and with and without surfactant. There was significant improvement in the rate of drug release from all 20 solid dispersions and the formulation (SD16) comprising Candesartan: containing Soluplus (1:3 ratio of drug:  Soluplus with 2% SLS as surfactant) by solvent evaporation process. Results Final optimized design SD16 contained maximum drug content of 99.08%. In in vitro dissolution studies it shows greater dissolution rate i.e. 99.7±4.2% associated through additional designs and pure drug. The drug was compatible with all the excipients as per FTIR (Fourier transform infrared spectroscopy). From powder X-ray diffraction (p-XRD) and by (SEM) studies it was evident that crystalline form of Candesartan has been converted into amorphous form within solid dispersion design.  Conclusion From these studies we can accomplish solid dispersions are one of the greatest favorable formulation for Candesartan cilexetil for enhancing the solubility and bioavailability of poorly water soluble drugs in the effective group of hypertension and other cardiac problems.

Authors and Affiliations

Bhikshapathi D. v. r. n.

Keywords

Related Articles

ELECTRONIC INFORMED CONSENT MODEL DEVELOPMENT FOR IMPLEMENTATION IN CLINICAL TRIALS IN UKRAINE

Objectives: The process of signing the informed consent (IC) is one of the essential procedures during organizing and conducting the clinical trial (CT) of any new drug. During this procedure, the volunteers should read...

CONTROLLED VESTIBULAR STIMULATION: PHYSIOLOGICAL INTERVENTION IN DIABETES CARE

ABSTRACTObjective: The present study was aimed to assess the role of vestibular stimulation in the management of diabetes care.Methods: We carried out the present study in 83-year-old man with 20 years history of Type 2...

PROTECTIVE EFFECT OF CASSIA FISTULA EXTRACTS AGAINST ULTRAVIOLET C INJURY IN HUMAN CORNEAL EPITHELIAL CELLS

Objective: The objective of this study was to investigate the antioxidant activity of Indian laburnum (Cassia fistula L. [CF]) leaf extracts and their impact on ultraviolet C (UVC) radiation-induced damage on human corne...

PROBIOTICS: THE UNDERVALUED CONQUERORS

ABSTRACTProbiotics or “beneficial microorganisms” have recently acquired the status of blockbusters in the pharmaceutical industry. Despite being commerciallyavailable, little is known about the magnitude to which th...

Download PDF file
  • EP ID EP608770
  • DOI -
  • Views 150
  • Downloads 0

How To Cite

Bhikshapathi D. v. r. n. (2019). DEVELOPMENT AND IN VITRO EVALUATION OF SOLID DISPERSIONS OF CANDESARTAN CILEXETIL. Asian Journal of Pharamceutical and Clinical Research, 12(2), 233-241. https://www.europub.co.uk/articles/-A-608770